Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer

Lapin, M; Edland, KH; Tjensvoll, K; Oltedal, S; Austdal, M; Garresori, H; Rozenholc, Y; Gilje, B; Nordga, O

Lapin, M (通讯作者),Stavanger Univ Hosp, N-4068 Stavanger, Norway.

CLINICAL CANCER RESEARCH, 2023; 29 (7): 1267

Abstract

Purpose: Circulating tumor DNA (ctDNA) has emerged as a promising tumor-specific biomarker in pancreatic cancer, but current evidence of the clinical ......

Full Text Link